Saninta 10% Povidone-iodine Liquid
NDC Package 68356-601-01
Package Information
Saninta 10% Povidone-iodine (povidone-iodine solution) liquids is clean the area.apply locally as needed. This formulation utilizes a liquid delivery system. Marketed by Lernapharm, this product is identified by NDC 68356-601 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 797730 - povidone-iodine 10 % Medicated Pad
- RxCUI: 797730 - povidone-iodine 100 MG/ML Medicated Pad
- RxCUI: 797730 - povidone-iodine 10 % (titratable iodine 1 % ) Medicated Pad
- RxCUI: 797730 - povidone-iodine 10 % Medicated Swabstick
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68356 - Lernapharm
- 68356-601 - Saninta 10% Povidone-iodine
- 68356-601-01 - 3 APPLICATOR in 1 POUCH / 2.3 mL in 1 APPLICATOR
- 68356-601 - Saninta 10% Povidone-iodine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68356-601). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68356-601-01 identifies a specific commercial package of 3 applicator in 1 pouch / 2.3 ml in 1 applicator of Saninta 10% Povidone-iodine, a human over the counter drug labeled by Lernapharm. This liquid is formulated for topical use and contains povidone-iodine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lernapharm on February 26, 2024. The current certification is valid through December 31, 2026.
How is this Lernapharm product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68356060101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.